Blockade of adenosine A 2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions

Experimental Neurology

Volumn 189, Issue 1, 2004, Pages 182-188

  Simola, Nicola ^a   Fenu, Sandro ^a   Baraldi, Pier G ^b   Tabrizi, Mojgan Aghazadeh ^b   Morelli, Micaela ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

A 2A antagonists; Parkinson; Striatum; Tacrine; Tremor

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; TACRINE; 2 FURAN 2 YL 7 3 (4 (4 (4 METHYLPIPERAZINE 1 SULFONYL)PHENYLETHYL) 7H PYRAZOLO(4,3 E)(1,2,4)TRIAZOLO (1,5 C)PYRIMDIN 5 YLAMINE); 2-FURAN-2-YL-7-3-(4-(4-(4-METHYLPIPERAZINE-1-SULFONYL)PHENYLETHYL)-7H-PYRAZOLO(4,3-E)(1,2,4)TRIAZOLO-(1,5-C)PYRIMDIN-5-YLAMINE); ADENOSINE A2A RECEPTOR; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CORPUS STRIATUM; DOSE RESPONSE; HYPOTHALAMUS NUCLEUS; JAW MOVEMENT; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SOLUBILITY; THALAMUS VENTRAL NUCLEUS; TREMOR; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; HISTOLOGY; JAW; MOVEMENT (PHYSIOLOGY); PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; TREMA;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; JAW; MALE; MOVEMENT; PARKINSONIAN DISORDERS; PIPERAZINES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; TACRINE; TIME FACTORS; TREMA; TRIAZOLES;

EID: 3543107307     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.05.027     Document Type: Article

References (24)

1. Baraldi P.G., Cacciari B., Romagnoli R., Spalluto G., Monopoli A., Ongini E., Varani K., Borea P.A. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2, 4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility. J. Med. Chem. 45:2002;115-126
2. Bibbiani F., Oh J.D., Petzer J.P., Castagnoli N. Jr., Chen J.F., Schwarzschild M.A., Chase T.N. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Exp. Neurol. 184:2003;285-294
3. Brown S.J., James S., Reddington M., Richardson P.J. Both A1 and A2a purine receptors regulate striatal acetylcholine release. J. Neurochem. 55:1990;31-38
4. Chase T.N., Bibbiani F., Bara-Jimenez W., Dimitrova T., Oh-Lee J.D. Translating A2A antagonist KW6002 from animal models to parkinsonian patients. Neurology. 61:2003;S107-S111
5. Correa M., Wisniecki A., Betz A., Dobson D.R., O'Neill M.F., O'Neill M.J., Salamone J.D. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behav. Brain Res. 148:2004;47-54
6. Cousins M.S., Carriero D.L., Salamone J.D. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. Eur. J. Pharmacol. 322:1997;137-145
7. Fenu S., Pinna A., Ongini E., Morelli M. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 321:1997;143-147
8. Ferré S., Fuxe K., Fredholm B.B., Morelli M., Popoli P. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487
9. Finn M., Jassen A., Baskin P., Salamone J.D. Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions. Pharmacol. Biochem. Behav. 57:1997;243-249
10. Grondin R., Bedard P.J., Hadj Tahar A., Gregoire L., Mori A., Kase H. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology. 52:1999;1673-1677
11. Kanda T., Jackson M.J., Smith L.A., Pearce R.K., Nakamura J., Kase H., Kuwana Y., Jenner P. Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann. Neurol. 43:1998;507-513
12. Kelley A.E., Bakshi V.P., Delfs J.M., Lang C.G. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity. Psychopharmacology. 99:1989;542-549
13. Koga K., Kurokawa M., Ochi M., Nakamura J., Kuwana Y. Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats. Eur. J. Pharmacol. 408:2000;249-255
14. Kurokawa M., Koga K., Kase H., Nakamura J., Kuwana Y. Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo. J. Neurochem. 66:1996;1882-1888
15. Mally J., Stone T.W. Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. J. Neurol. Sci. 132:1995;129-132
16. Mally J., Stone T.W. Potential role of adenosine antagonist therapy in pathological tremor disorders. Pharmacol. Ther. 72:1996;243-250
17. Morelli M. Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease. Exp. Neurol. 184:2003;20-23
18. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, Sidney
19. Pinna A., Di Chiara G., Wardas J., Morelli M. Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats. Eur. J. Neurosci. 8:1996;1176-1181
20. Pinna A., Corsi C., Carta A.R., Valentini V., Pedata F., Morelli M. Modification of adenosine extracellular levels and adenosine A2A receptor mRNA by dopamine denervation. Eur. J. Pharmacol. 446:2002;75-82
21. Pollack A.E., Fink J.S. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. Brain Res. 743:1996;124-130
22. Salamone J., Baskin P. Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor. Pharmacol. Biochem. Behav. 53:1996;179-183
23. Salamone J.D., Johnson C.J., McCullough L.D., Steinpreis R.E. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology. 102:1990;529-534
24. Salamone J.D., Mayorga A.J., Trevitt J.T., Cousins M.S., Conlan A., Nawab A. Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog. Neurobiol. 56:1998;591-611